Skip to content

To evaluate the clinical efficacy of eliminating phlegm and removing blood stasis and invigorating qi and warming yang in the treatment of coronary heart disease complicated with bradycardia

To evaluate the clinical efficacy of eliminating phlegm and removing blood stasis and invigorating qi and warming yang in the treatment of coronary heart disease complicated with bradycardia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011791
Enrollment
Unknown
Registered
2017-06-28
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease with slow arrhythmia

Interventions

Basic Western medicine + Chinese medicine granules group:Western medicine treatment with conventional coronary heart disease
Basic Western medicine + Chinese medicine compound group:Western medicine treatment with conventional coronary heart disease
Basic Western medicine group:Conventional coronary heart disease western medicine treatment

Sponsors

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. meet the coronary heart disease with slow arrhythmia diagnostic criteria of Western medicine; 2. accord with coronary heart disease with slow arrhythmia, Phlegm Blood Stasis knot, Yang Qi deficiency syndrome diagnostic criteria of traditional Chinese medicine; 3. Aged 40 to 80 years; 4. can provide detailed liaison, no short-term migration, willing to cooperate with follow-up; 5. voluntary participation in clinical trial research and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. It is speculated that the life expectancy of the subjects is less than 6 months, with severe primary diseases such as heart, lung and kidney; 2. severe hypertension, cardiovascular and cerebrovascular, liver, kidney, hematopoietic system and other serious primary disease subjects; 3. neurological and metabolic dysfunction, drug induced sinus node impulse formation and conduction disorders; 4. the disease caused treatment and evaluation difficulties (such as cancer, infection, severe metabolic diseases, etc.); 5. nearly two months to participate in other researchers; 6. allergic constitution or allergic to the application of drugs in this institute; 7. psychiatric patients or other reasons due to educational level, language barriers and other reasons can not meet the normal test research process; 8. pregnant or lactating women; 9. take the traditional Chinese medicine preparation with similar effect in the last 4 weeks; 10. pacemaker implantation or pacemaker implantation absolute indications.

Design outcomes

Primary

MeasureTime frame
Cardiac color Doppler ultrasonography;ECG measurement;Safety index;TCM Comprehensive syndrome observation table;Seattle angina pectoris scale;Angina pectoris, symptom, curative effect;

Countries

China

Contacts

Public ContactHou Ping

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

houping57@126.com+86 13322403599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026